Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-20-034286

President and CEO acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stergiou Angelos M. President and CEO 2020-03-12 Grant or award +95,000 95,000 D
Derivatives
Stergiou Angelos M. President and CEO 2020-03-12 Grant or award · Stock Option (Right to Buy) +70,000 70,000 D
Loading xslF345X03/tm2012902-3_form4.xml…